Target intelligence / Profile preview

Ferriprotoporphyrin IX (Fe(III)PPIX) (Fe(III)PPIX)

Target
Fe(III)PPIX
Molecular classification
Metalloporphyrin, Other
01

Overview

Ferriprotoporphyrin IX (heme) is a vital metabolic byproduct and therapeutic target located within the acidic food vacuole of the malaria parasite Plasmodium falciparum (Sigala & Goldberg, 2014). During the parasite's intraerythrocytic stage, it digests host hemoglobin to obtain amino acids, a process that releases toxic, redox-active free heme (Sullivan, 2002). To prevent cellular damage, the parasite detoxifies this heme by sequestering it into an insoluble crystalline polymer called hemozoin (Egan, 2008). Antimalarial drugs, most notably the 4-aminoquinolines like chloroquine, target this pathway by binding to the heme monomers or the growing faces of hemozoin crystals (Hempelmann, 2007). This binding inhibits further crystallization, leading to an accumulation of toxic heme-drug complexes that cause membrane lipid peroxidation and parasite death (Coronado et al., 2014). Consequently, the disruption of heme detoxification remains one of the most successful strategies in antimalarial chemotherapy.

Other names
HemeHematinFree hemeProtoporphyrin IX iron(III) complexMalaria pigment precursor
02

Mechanism of action

Inhibition of hemozoin biocrystallization and formation of toxic heme-drug complexes.

03

Biological functions

Cell deathOther
04

Disease associations

InfectionMalaria
05

Safety considerations

Drug resistance (e.g., PfCRT mutations)RetinopathyCardiotoxicity (QT prolongation)Neurotoxicity
06

Interacting drugs

Chloroquine

9 more in the full profile.

07

Biomarkers

Hemozoin levelsParasite clearance rate

Beyond the preview

Go deeper on Ferriprotoporphyrin IX (Fe(III)PPIX) (Fe(III)PPIX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferriprotoporphyrin IX (Fe(III)PPIX) (Fe(III)PPIX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call